Company Filing History:
Years Active: 2025
Title: Renxiang Chen: Innovator in mRNA Vaccine Technology
Introduction
Renxiang Chen is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of mRNA vaccines. His work is crucial in the fight against infectious diseases, including the novel coronavirus.
Latest Patents
Renxiang Chen holds a patent for "Compositions and methods of mRNA vaccines against novel coronavirus infection." This patent describes a ribonucleic acid (RNA) encoding a spike (S) protein or an immunogenic fragment of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The invention includes at least one non-naturally occurring amino acid mutation, with some embodiments derived from a delta variant. The patent also covers relevant polynucleotides, vectors, cells, compositions, kits, production methods, and methods of use.
Career Highlights
Renxiang Chen is associated with Rnaimmune, Inc., where he continues to advance his research and development efforts. His innovative approach to vaccine technology has positioned him as a key player in the biotechnology sector.
Collaborations
Renxiang has collaborated with notable colleagues, including Neeti Ananthaswamy and Yong-Sik Bong. These partnerships enhance the research and development capabilities within his field.
Conclusion
Renxiang Chen's contributions to mRNA vaccine technology exemplify the impact of innovation in addressing global health challenges. His work continues to pave the way for advancements in vaccine development and infectious disease prevention.